Paloma Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-18,978
| Closed | -$57K | – | 628 |
|
|
2022
Q1 | $57K | Buy |
18,978
+6,447
| +51% | +$19.4K | ﹤0.01% | 1227 |
|
|
2021
Q4 | $49K | Buy |
+12,531
| New | +$49K | ﹤0.01% | 1450 |
|
|
2020
Q1 | – | Sell |
-19,674
| Closed | -$55K | – | 1065 |
|
|
2019
Q4 | $55K | Buy |
+19,674
| New | +$55K | ﹤0.01% | 1773 |
|
|
2019
Q3 | – | Sell |
-157,300
| Closed | -$327K | – | 1563 |
|
|
2019
Q2 | $327K | Buy |
+157,300
| New | +$327K | 0.01% | 1017 |
|